Search Results - "Stjepanovic, N"

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Stjepanovic, N., Moreira, L., Carneiro, F., Balaguer, F., Cervantes, A., Balmaña, J., Martinelli, E.

Get full text

Ocular toxicities of MEK inhibitors and other targeted therapies by Stjepanovic, N., Velazquez-Martin, J.P., Bedard, P.L.

“…Many classes of anticancer therapy, including chemotherapeutic agents, hormonal and molecular targeted treatments, can produce ocular toxicity. Novel agents…”
Get full text

Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence by Usmani, Omar S, Roche, Nicolas, Jenkins, Martin, Stjepanovic, Neda, Mack, Peter, De Backer, Wilfried

“…Metered dose inhalers (MDIs) are one of the most common device types for delivering inhaled therapies. However, there are several technical challenges in…”
Get full text

Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons by Hurst, John R, Gruffydd-Jones, Kevin, Biswas, Mousumi, Guranlioglu, Deniz, Jenkins, Martin, Stjepanovic, Neda, Bamrara, Arushi

“…Background: This literature review assessed comparative efficacy and safety of long-acting muscarinic antagonist/long-acting [[beta].sub.2]-agonist (LAMA/LABA)…”
Get full text

Soybean meal improves the physical quality of extruded fish feed by Sørensen, M., Stjepanovic, N., Romarheim, O.H., Krekling, T., Storebakken, T.

“…The study was designed to investigate effects of processing of soybean meal on physical quality of extruded fish feed. Three diets were produced; one fish meal…”
Get full text

First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848) by Gazzah, A, Stjepanovic, N, Ryu, M.H, Tabernero, J, Soria, J.C, Bedard, P, Kang, Y.K, Bahleda, R, Guillemin-Paveau, H, Henry, C, Hatteville, L, Zilocchi, C, Demers, B, Hierro, C

“…An abstract of the study by Gazzah et al evaluating the first-in-human phase I trial of the anti-CEACAM5 antibody-drug conjugate SAR408701 in patients with…”
Get full text

Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines by Stjepanovic, Ana N., Todorovic, Nemanja B., Tesic, Tamara Z., Komazec, Zoran S., Canji-Panic, Jelena M., Lalic-Popovic, Mladena N.

Get full text

Synthetic study on the angular triquinanes by Stjepanovic, Mihailo, Jankovic, Aleksandar, Vulovic, Bojan, Matovic, Radomir, Saicic, Radomir

“…The synthesis of an angular triquinane, which could serve as a suitable platform for the synthesis of several natural products (panaginsene, silphinene,…”
Get full text

EARLY AND SUSTAINED ASTHMA CONTROL OVER 24 WEEKS AFTER TEZEPELUMAB INITIATION: REAL-WORLD ASCENT STUDY by Milger-Kneidinger, K., Gessner, C., Dorscheid, D., LLanos, J., Nåtman, J., Emmanuel, B., Le, T., Stjepanovic, N.

“…Randomized controlled trials have demonstrated the efficacy of tezepelumab in patients with severe, uncontrolled asthma (SUA). This interim analysis of the…”
Get full text

LBA13 Dostarlimab + chemotherapy (CT) vs pembrolizumab + CT in metastatic non-squamous non-small cell lung cancer (NSCLC): Updated Asian subgroup analyses of the PERLA trial by Lee, D.H., Ahn, J.S., Lin, S-H., Ulanska, M., Lopez, G.A., Chian, C-F., Cho, L., Szijgyarto, Z., Stjepanovic, N., Lim, S.M.

Get full text

LBA64 Overall survival from a phase II randomised double-blind trial (PERLA) of dostarlimab (dostar) + chemotherapy (CT) vs pembrolizumab (pembro) + CT in metastatic non-squamous NSCLC by Peters, S., Ortega Granados, A.L.O., de Marinis, F., Lo Russo, G., Schenker, M., Arriola, E., Puig, J.M., Lee, D.H., Reck, M., Szijgyarto, Z., Buss, E., Stjepanovic, N., Lim, S.M.

Get full text

Multikinase inhibitors in the treatment of thyroid cancer : specific role of lenvatinib by Stjepanovic, Neda, Capdevila, Jaume

“…Focuses on multikinase inhibitors and the specific role of lenvatinib in the treatment of advanced thyroid cancer. Source: National Library of New Zealand Te…”
Get full text

Abstract P5-09-04: Impact of premenopausal RRSO on breast cancer risk in BRCA1/2 mutation carriers: Maximizing bias-reduction by Stjepanovic, N, Villacampa, G, Nead, K, Torres, S, Gomez, L, Nathanson, KL, Teule, A, Brunet, J, Ramon y Cajal, T, Llort, G, Dienstmann, R, Rue, M, Domchek, S, Balmana, J

“…Abstract Background: To prevent ovarian cancer in BRCA1/2 mutation carriers, risk reducing salpingo-oophorectomy (RRSO) is recommended around age 40. In women…”
Get full text

Abstract P2-05-19: Impact of TP53 functional mutation type on clinical outcomes of advanced breast cancer patients by Stjepanovic, N, Garg, S, Berman, H, Warr, D, Amir, E, Cescon, D, Elser, C, Wang, L, Kamel-Reid, S, Siu, L, Bedard, PL, Stockley, T

“…Abstract Background: Next-generation sequencing (NGS) has improved our understanding of breast cancer (BC) biology. Somatic TP53 mutations (TP53m) are present…”
Get full text

Change of natural history of hereditary diffuse gastric cancer after identification of a novel CDH1 mutation by Stjepanovic, N., Castro, S., Gadea, N., Carrasco, E., Codina, M., Lopez, A., Semidey, M.E., De Torres, I.M., Alsina, M., Urioste, M., Pena, L., Mercadillo, F., Landolfi, S., Balmana, J.

Get full text

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Stjepanovic, N, Moreira, L, Carneiro, F, Balaguer, F, Cervantes, A, Balmaña, J, Martinelli, E

Get full text

23 - First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848) by Gazzah, A., Stjepanovic, N., Ryu, M.H., Tabernero, J., Soria, J.C., Bedard, P., Kang, Y.K., Bahleda, R., Guillemin-Paveau, H., Henry, C., Hatteville, L., Zilocchi, C., Demers, B., Hierro, C.

Get full text

Germline and somatic multi-gene sequencing in patients (pts) with advanced high grade serous ovarian cancer (HGSOC) and triple negative breast cancer (TNBC) by Stjepanovic, N., Wilson, M., Mandilaras, V., Clarke, B., Berman, H., Kim, R.H., Lheureux, S., Armel, S. Randall, McCuaig, J., Volenik, A., Demsky, R., Chow, H., Mysura, M., Siu, L., Bedard, P., Kamel-Reid, S., Stockley, T., Oza, A.

Get full text

Abstract P3-09-05: Clinical outcome of patients with advanced triple negative breast cancer with germline and somatic variants in homologous recombination gene by Stjepanovic, N, Kim, RH, Wilson, M, Mandilaras, V, Berman, H, Amir, E, Cescon, D, Elser, C, Randall Armel, S, McCuaig, J, Volenik, A, Demsky, R, Chow, H, Misyura, M, Wang, L, Oza, AM, Kamel-Reid, S, Stockley, T, Bedard, PL

“…Abstract Background: Variants in homologous recombination (HR) genes other than BRCA1/2 may cause a BRCA-like phenotype triple negative breast cancer (TNBC),…”
Get full text

An attemp to use a pulsed CO2 laser for decontamination of radioactive metal surfaces by MILAN S. TRTICA, SCEPAN S. MILJANIC, NATASA N. STJEPANOVIC

“…There is a growing interest in laser radioactive decontamination of metal surfaces. It offers advantages over conventional methods: improved safety, reduction…”
Get full text